Skip to main content
Watch Insiders
CBIOHealthcare

Gyre Therapeutics Inc (CBIO) Insider Trading

In the last 90 days, 7 Gyre Therapeutics Inc (CBIO) insiders reported no open-market purchases and 7 sales totaling $285,501. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 18, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 18, 2026Joshua T BrummChief Executive OfficerSale9,447$16.91$159,775
Sep 18, 2026Jonathan McNeillPresident and COOSale4,570$16.90$77,234
Sep 16, 2026Ryan LynchSee RemarksSale240$17.90$4,296
Sep 16, 2026Jan PinkasChief Scientific OfficerSale658$17.90$11,778
Sep 16, 2026Ellie Eunkyung ImChief Medical OfficerSale623$17.90$11,152
Sep 16, 2026Richard William ScalzoChief Financial OfficerSale568$17.90$10,167
Sep 16, 2026Barbara Harlin BisphamSee RemarksSale620$17.90$11,098
Jul 16, 2026Peter Evan HarwinCorporate insiderOpen Market Purchase853,450$14.50$12,375,025
Jul 16, 2026Fairmount Healthcare Fund II L.P.Corporate insiderOpen Market Purchase853,450$14.50$12,375,025
Jul 16, 2026Fairmount Funds Management LLCCorporate insiderOpen Market Purchase853,450$14.50$12,375,025
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

CBIO insider trading FAQ

Are CBIO insiders buying or selling?
Over the last 90 days, CBIO insiders were net sellers, reporting $0.00 of open-market purchases and $285,501 of sales.
When was the last CBIO insider purchase?
No open-market insider purchase of Gyre Therapeutics Inc stock was reported in the last 90 days.
Where does CBIO insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Gyre Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.